ondansetron has been researched along with Stomach Ulcer in 9 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Stomach Ulcer: Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We used the murine re-fed indomethacin (IND) experimental ulcer model." | 8.31 | Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT ( Akiba, Y; Kaunitz, JD; Satoh, H; Urushidani, T, 2023) |
| "Fluvoxamine with different administration routes and ondansetron monotherapy before stress reduce the occurrence of gastric ulcers, while the combination drugs did not increase the protective effect of the gastric mucosa." | 8.02 | Gastroprotective effect of fluvoxamine and ondansetron on stress-induced gastric ulcers in mice. ( Agung Dewaandika, W; Andarsari, MR; Aryani, T; Oktavia Hanaratri, E; Rahmadi, M; Su'aida, N; Yustisari, P, 2021) |
| "The effect of central administration of ondansetron, a 5-hydroxytryptamine-3 (5-HT3) receptor antagonist on gastric secretion and gastric cytoprotection was evaluated using four different models of gastric ulcers and cysteamine induced duodenal ulcer." | 7.75 | Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers. ( Asad, M; Dhamanigi, SS; Prasad, VS; Ramesh, ST, 2009) |
| "We used the murine re-fed indomethacin (IND) experimental ulcer model." | 4.31 | Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT ( Akiba, Y; Kaunitz, JD; Satoh, H; Urushidani, T, 2023) |
| "Fluvoxamine with different administration routes and ondansetron monotherapy before stress reduce the occurrence of gastric ulcers, while the combination drugs did not increase the protective effect of the gastric mucosa." | 4.02 | Gastroprotective effect of fluvoxamine and ondansetron on stress-induced gastric ulcers in mice. ( Agung Dewaandika, W; Andarsari, MR; Aryani, T; Oktavia Hanaratri, E; Rahmadi, M; Su'aida, N; Yustisari, P, 2021) |
| "The effect of central administration of ondansetron, a 5-hydroxytryptamine-3 (5-HT3) receptor antagonist on gastric secretion and gastric cytoprotection was evaluated using four different models of gastric ulcers and cysteamine induced duodenal ulcer." | 3.75 | Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers. ( Asad, M; Dhamanigi, SS; Prasad, VS; Ramesh, ST, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Satoh, H | 1 |
| Akiba, Y | 1 |
| Urushidani, T | 1 |
| Kaunitz, JD | 1 |
| Rahmadi, M | 1 |
| Su'aida, N | 1 |
| Yustisari, P | 1 |
| Agung Dewaandika, W | 1 |
| Oktavia Hanaratri, E | 1 |
| Andarsari, MR | 1 |
| Aryani, T | 1 |
| Burns, RA | 1 |
| Schmidt, SM | 1 |
| Ramesh, ST | 1 |
| Asad, M | 1 |
| Dhamanigi, SS | 1 |
| Prasad, VS | 1 |
| Debnath, S | 1 |
| Biswas, D | 1 |
| Ray, K | 1 |
| Guha, D | 1 |
| Ogle, CW | 2 |
| Hui, SC | 2 |
| Cho, CH | 1 |
| Koo, MW | 1 |
| Ko, JK | 1 |
| Takeuchi, K | 1 |
| Kato, S | 1 |
| Hirata, T | 1 |
| Nishiwaki, H | 1 |
| Qiu, BS | 1 |
| Li, KM | 1 |
9 other studies available for ondansetron and Stomach Ulcer
| Article | Year |
|---|---|
Gastroparesis Worsens Indomethacin-Induced Gastric Antral Ulcers by Bile Reflux via Activation of 5-HT
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Apomorphine; Atropine; Bile Reflux; C | 2023 |
Gastroprotective effect of fluvoxamine and ondansetron on stress-induced gastric ulcers in mice.
Topics: Animals; Fluvoxamine; Gastric Mucosa; Mice; Ondansetron; Pharmaceutical Preparations; Rats, Wistar; | 2021 |
Portal venous gas emboli after accidental ingestion of concentrated hydrogen peroxide.
Topics: Abdominal Pain; Antiemetics; Child; Embolism, Air; Fluid Therapy; Hematemesis; Humans; Hydrogen Pero | 2013 |
Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers.
Topics: Animals; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastric Ac | 2009 |
Moringa oleifera induced potentiation of serotonin release by 5-HT(3) receptors in experimental ulcer model.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Disease Models, Animal; Enterochromaffin Cells; Female; Male; M | 2011 |
The influence of peripheral or central administration of ondansetron on stress-induced gastric ulceration in rats.
Topics: Animals; Cell Degranulation; Cold Temperature; Female; Injections, Intraventricular; Injections, Sub | 1995 |
Modulatory role of 5-HT3 receptors in gastric function and ethanol-induced mucosal damage in rat stomachs.
Topics: Animals; Blood Flow Velocity; Dose-Response Relationship, Drug; Ethanol; Gastric Acid; Gastric Mucos | 1994 |
Gastric motility and mucosal ulcerogenic responses induced by prokinetic drugs in rats under prostaglandin-deficient conditions.
Topics: Animals; Cisapride; Dose-Response Relationship, Drug; Gastric Acid; Gastric Emptying; Gastric Mucosa | 1997 |
5-Hydroxytryptamine3-receptor blockade protects against gastric mucosal damage in rats.
Topics: Animals; Cold Temperature; Cyproheptadine; Dose-Response Relationship, Drug; Ethanol; Female; Gastri | 1992 |